compound introduction
ALW-II-49-7 is a selective EphB2 kinase inhibitor with an EC 50 value of 40 nM in cell In Vitro ALW-II-49-7 (compound 9) exhibits selectivity profile of binding to a set of kinases including b-raf, CSF1R, DDR1, DDR2, EphA2, EphA5, EphA8, EphB1, EphB2, EphB3, Frk, Kit, Lck, p38a, p38b, PDGFRa, PDGFRb, and Raf1. ALW-II-49-7 (0.01-10 μM; 1 h) inhibits EphB2 tyrosine kinase activity in U87 glioblastoma cells. EphB2 is added in media at 2 μg/mL. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:EphB2
